Tissue microarray technology in breast cancer subtyping

Nieminen, Anssi

dc.contributor.author	Nieminen, Anssi
dc.date.accessioned	2008-10-15T06:32:09Z
dc.date.available	2008-10-15T06:32:09Z
dc.date.issued	2008
dc.identifier.other	oai:jykdok.linneanet.fi:1071288
dc.identifier.uri	https://jyx.jyu.fi/handle/123456789/18987
dc.format.extent	62 sivua
dc.format.mimetype	application/pdf
dc.language.iso	eng
dc.rights	This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.	en
dc.rights	Julkaisu on tekijänoikeussäännösten alainen. Teosta voi lukea ja tulostaa henkilökohtaista käyttöä varten. Käyttö kaupallisiin tarkoituksiin on kielletty.	fi
dc.subject.other	tissue microarray technology
dc.subject.other	breast cancer
dc.subject.other	breast carcinoma
dc.subject.other	immunohistochemistry
dc.subject.other	cancer marker
dc.title	Tissue microarray technology in breast cancer subtyping
dc.identifier.urn	URN:NBN:fi:jyu-200810095796
dc.type.dcmitype	Text	en
dc.type.ontasot	Pro gradu -tutkielma	fi
dc.type.ontasot	Master’s thesis	en
dc.contributor.tiedekunta	Matemaattis-luonnontieteellinen tiedekunta	fi
dc.contributor.tiedekunta	Faculty of Sciences	en
dc.contributor.laitos	Bio- ja ympäristötieteiden laitos	fi
dc.contributor.laitos	Department of Biological and Environmental Science	en
dc.contributor.yliopisto	University of Jyväskylä	en
dc.contributor.yliopisto	Jyväskylän yliopisto	fi
dc.contributor.oppiaine	Solu- ja molekyylibiologia	fi
dc.contributor.oppiaine	Cell and molecular biology	en
dc.rights.accesslevel	openAccess	fi
dc.type.publication	masterThesis
dc.contributor.oppiainekoodi	4013
dc.subject.yso	rintasyöpä
dc.format.content	fulltext
dc.type.okm	G2

Aineistoon kuuluvat tiedostot

Nimi:: URN_NBN_fi_jyu-200810095796.pdf
Koko:: 1.388Mb
Tiedostomuoto:: PDF

Katso/Avaa

Aineisto kuuluu seuraaviin kokoelmiin

Pro gradu -tutkielmat [28092]

Näytä suppeat kuvailutiedot

Näytetään aineistoja, joilla on samankaltainen nimeke tai asiasanat.

Validation of the breast cancer Analysis Protocol Packages (APPs) for the determination of estrogen and progesterone receptors (ER, PR), human epidermal growth factor recep- tor 2 (HER2) and proliferation index (Ki67) in breast cancer

Heikinmäki, Nella (2022)

Rintasyöpä on naisten yleisin syöpä maailmassa. Sillä on merkittävä vaikutus kansanterveyteen sekä yhteiskuntaan ja tämän vuoksi sitä on tutkittu laajasti jo pitkään. Tämän opinnäytetyön tarkoituksena on validoida kaupallisen ...
Does breast carcinoma belong to the Lynch syndrome tumor spectrum? : Somatic mutational profiles vs. ovarian and colorectal carcinomas

Porkka, Noora K.; Olkinuora, Alisa; Kuopio, Teijo; Ahtiainen, Maarit; Eldfors, Samuli; Almusa, Henrikki; Mecklin, Jukka-Pekka; Peltomäki, Päivi (Impact Journals LLC, 2020)

Inherited DNA mismatch repair (MMR) defects cause predisposition to colorectal, endometrial, ovarian, and other cancers occurring in Lynch syndrome (LS). It is unsettled whether breast carcinoma belongs to the LS tumor ...
Quantitative multiplexed analysis of indoleamine 2,3-dioxygenase (IDO) and arginase-1 (ARG1) expression and myeloid cell infiltration in colorectal cancer

Elomaa, Hanna; Härkönen, Jouni; Väyrynen, Sara A.; Ahtiainen, Maarit; Ogino, Shuji; Nowak, Jonathan A.; Lau, Mai Chan; Helminen, Olli; Wirta, Erkki-Ville; Seppälä, Toni T.; Böhm, Jan; Mecklin, Jukka-Pekka; Kuopio, Teijo; Väyrynen, Juha P. (Elsevier, 2024)

Indoleamine 2,3-dioxygenase (IDO) and Arginase-1 (ARG1) are amino acid metabolizing enzymes frequently highly expressed in cancer. Their expression may deplete essential amino acids, lead to immunosuppression, and promote ...
Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer : Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation

Salama, Eid E.; Youssef, Mohamed F.; Aboelmagd, Ahmed; Boraei, Ahmed T. A.; Nafie, Mohamed S.; Haukka, Matti; Barakat, Assem; Sarhan, Ahmed A. M. (MDPI AG, 2023)

According to data provided by the World Health Organization (WHO), a total of 2.3 million women across the globe received a diagnosis of breast cancer in the year 2020, and among these cases, 685,000 resulted in fatalities. ...
Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients

Lehto, Niina (2020)

Kolmoisnegatiivinen rintasyöpä (TNBC) kattaa 10–15 % kaikista rintasyövistä. TNBC:ssä kasvaimen soluissa ei ole hormonireseptoreita eikä HER2-onkogeeni ole monistunut, sairaus etenee nopeasti ja hoitovaihtoehtoja on vähän. ...

Tissue microarray technology in breast cancer subtyping

Aineistoon kuuluvat tiedostot

Aineisto kuuluu seuraaviin kokoelmiin

Samankaltainen aineisto

Validation of the breast cancer Analysis Protocol Packages (APPs) for the determination of estrogen and progesterone receptors (ER, PR), human epidermal growth factor recep- tor 2 (HER2) and proliferation index (Ki67) in breast cancer ﻿

Does breast carcinoma belong to the Lynch syndrome tumor spectrum? : Somatic mutational profiles vs. ovarian and colorectal carcinomas ﻿

Quantitative multiplexed analysis of indoleamine 2,3-dioxygenase (IDO) and arginase-1 (ARG1) expression and myeloid cell infiltration in colorectal cancer ﻿

Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer : Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation ﻿

Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients ﻿

Validation of the breast cancer Analysis Protocol Packages (APPs) for the determination of estrogen and progesterone receptors (ER, PR), human epidermal growth factor recep- tor 2 (HER2) and proliferation index (Ki67) in breast cancer

Does breast carcinoma belong to the Lynch syndrome tumor spectrum? : Somatic mutational profiles vs. ovarian and colorectal carcinomas

Quantitative multiplexed analysis of indoleamine 2,3-dioxygenase (IDO) and arginase-1 (ARG1) expression and myeloid cell infiltration in colorectal cancer

Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer : Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation

Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients